SCHEMBL28050769

SCHEMBL28050769

CCOC(=O)c1c(Cl)ncc(C)c1Cl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
CA14 Q9ULX7 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
CYP3A4 P08684 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
NR1H2 P55055 1/20 0.42
NR1H3 Q13133 1/20 0.42
ALDH1A1 P00352 5/20 0.41
MAPT P10636 3/20 0.41
NPC1 O15118 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
TP53 P04637 1/20 0.41
XBP1 P17861 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22445772 0.80 ALDH1A1 (0.48) CA12CA1CA2CA7CA9
SCHEMBL27904171 0.79 POLB (0.50) SMN1; SMN2CYP3A4TDP1ALDH1A1MAPK1
SCHEMBL16274616 0.79 CA12 (0.48) CA12CA1CA2CA7CA9
SCHEMBL31426578 0.78 HTT (0.41) CA12CA1CA2CA7CA9
SCHEMBL28036249 0.77 SMN1; SMN2 (0.48) SMN1; SMN2CYP3A4ALDH1A1MAPK1HSD17B10
SCHEMBL2527607 0.77 CA12 (0.47) CA12CA1CA2CA7CA9
SCHEMBL7669745 0.77 MAPT (0.48) SMN1; SMN2TDP1ALDH1A1MAPTNPC1
SCHEMBL3110696 0.75 PDE4D (0.46) CA12CA1CA2CA7CA9
SCHEMBL30624542 0.75 PDE4D (0.46) CA12CA1CA2CA7CA9
SCHEMBL1061527 0.75 PDE4D (0.46) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105384738-A Heterocyclic compound as protein kinase inhibitor and preparation method and application thereof KECHOW PHARMA INC 2016-03-09 CN disclosed